It's not been launched. It's been released into a test phase for feedback from ambassadors. You can't buy it yet.
The best indication in the presentation was that actual commercial launch will be after CUV156 and CUV151 results, but there was no specific guidance in the slides as to when that might be. The Communique they released in late August put first results for both those trials in 2022, without being more specific than that.
My guess is they planned on a proper launch at this event (why else would you drag in Royalty, Finance ministers, Michelin starred cuisine?) but there was some kind of delay (again) and what we got instead was a presentation focused on the social media strategy for a non core business.
OTC Novel product range, page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $664.8M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |